{"groups":[{"description":"Visilizumab, Tacrolimus and Methotrexate. All participants.","id":"FG000","title":"First Study Stage: Study Treatment"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"8"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"8"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}],"preAssignmentDetails":"The study was closed during the single-arm, first stage and did not proceed to the second stage comparison to antithymocyte globulin (ATG) in combination with tacrolimus/methotrexate as originally planned.","recruitmentDetails":"Participants were enrolled at Moffitt Cancer Center between February 2008 and April 2010."}